VIDEOS

Como parte de la Videoteca de Cáncer de Pulmón en Español 2023, el Dr. Alejandro R. Calvo, MD, FACP, aborda temas relacionados con el cáncer de pulmón...

In these videos, the panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and looks at data from the Laura Trial...

For this year's post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center, and Founder and...

2025 동아시아 폐암 이미지 라이브러리의 일환으로 서정민 박사(분당서울대학교병원)가 절제 가능한 비소세포 폐암의 수술 주변 관리에 대해 논의합니다. 2025 동아시아 폐암 영상 라이브러리의 일환으로, 김진용 박사(삼성메디컬센터)는 EGFR 돌연변이가 있는 비소세포...

For the 2025 Case Based Panel Discussions, a panel of oncologists consisting of Dr. Isabel Preeshagul, Dr. Deborah Doroshow and Dr. Christine Garcia...

ARTICLES

Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!

As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.

GRACE is pleased to announce the acceptance of four rising stars into the 7th year of the GRACE Patient Education Ambassadors Program for the 2025-26...

Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias...

COMMUNITY FORUM

Our 2025 Spanish Targeted Therapies in Lung Cancer Patient Forum LIVE Webinar is coming up on Saturday, August 9, 2025 . Patients and caregivers can...
A special thank you goes out to our sponsors Exelixis and Janssen for helping make the 2024-2025 Patient Education Ambassadors Program possible! All...
A special thank you goes out to our sponsors Genentech and AstraZeneca for helping make the 2025 Case-Based Panel Discussions possible!
A special thank you goes out to our sponsor Bristol-Myers Squibb for helping make the 2025 East Asian Lung Cancer Video Library possible!
A special thank you goes out to our sponsors Summit and Janssen for helping make the 2025 Lung Cancer Video Library possible!

Recent Comments

This is such a difficult…
Comment By JanineT GRACE … on Aug 13, 2025 9:22 am
Specialist
Comment By JanineT GRACE … on Aug 13, 2025 9:22 am
Hi Happybluesun, I'm glad…
Comment By JanineT GRACE … on Aug 13, 2025 9:22 am
Advice, please.
Comment By JanineT GRACE … on Aug 13, 2025 9:22 am

East Asian Lung Cancer Video Llibrary 2025

Video

2025 동아시아 폐암 이미지 라이브러리의 일환으로 서정민 박사(분당서울대학교병원)가 절제 가능한 비소세포 폐암의 수술 주변 관리에 대해 논의합니다. 

2025 동아시아 폐암 영상 라이브러리의 일환으로, 김진용 박사(삼성메디컬센터)는 EGFR 돌연변이가 있는 비소세포 폐암 환자를 위한 표적 치료에 대해 논의합니다.

What is the AVO treatment for Chronic Lymphocytic Leukemia (CLL)? Acalabrutinib, Venetoclax, Obinutuzumab for High-Risk Patients

Article

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.

Survivors Month/Glad to be Here

June is National Cancer Survivors Month.  As with many terms used in cancer, not everyone who has incurable cancer sees themselves as a survivor if they aren't going to survive cancer, and some people are happy to take on the mantle of "survivor", no matter the prognosis.

 

I joined GRACE as a caregiver for my husband who had a Pancoast tumor, NSCLC stage III in 2009. He had curative chemo/rads then it was believed he had a recurrence in the spine/oligometastasis that was radiated. He's 10 years out from treatment.
Subscribe to In Treatment